Multinational corporations (MNCs) have traditionally reigned king in the Indian healthcare traditional landscape as far as reliability is concerned. Over the decades, the reasoning was straightforward: the larger budgets the better quality. Nevertheless, a great change is taking place in the clinics and hospitals in India. More and more medical workers, in particular women health specialists are reposed in PCD (Propagated Cummins Distribution) pharma brands.
However, what is the cause of this shift? Why would a physician jeopardize his reputation with an expanding PCD name when there is a giant in the world?
The solution is a combination of agility, specialization and the changing ecosystem of the Gynae PCD pharma franchise model.
- Niche Specialization vs. Mass Production.
Whereas multinational brands tend to be all-purpose, PCD companies that are successful tend to have a niche in certain therapeutic areas. In gynecology, nothing is missed.
The doctors are discovering that Gynae-centric PCD firms make a full commitment to their supply chain and their research and development, concentrating on the health of women, including the hormonal equilibrium, prenatal supplements, and infertility treatments. Such an expert strategy tends to lead to more customized formulations suited to the requirements of the Indian patient population more specifically than a global product that is a one-fits-all approach.
- The Bridge of Local Accountability.
The local face is one of the largest benefits of the PCD model. In the case of a doctor collaborating with an agent of a local franchise, a certain degree of personal responsibility is achieved, and MNCs fail to achieve the same.
The PCD franchise owner is only a phone call away in case there is a query about a batch, a request about clinical data, urgent stock. This localization service will mean that the practice of the doctor will never experience the lack of needed medications in order to develop a relationship built on trust and reciprocal development.
- Quality Equity at Moral Pricing.
The supposition that the more expensive the good, the better quality it is, is dying. After the strict application of WHO-GMO and ISO standards on Indian manufacturing units, PCD brands are now the same chemical efficacy as those of their multinational counterparts.
Physicians are becoming more conscious of the fact that when they franchise a Gynae PCD, they will be able to offer their patients quality treatment at a fraction of the price. In a price-sensitive market such as India, the ability to prescribe a low-cost but effective treatment plan is much better in enhancing patient compliance and patient outcomes.
- Innovation and Rapid Market entry.
Global corporate hierarchies and red tape tend to snarl up the multinational brands. On the contrary, PCD pharma corporations are nimble. They will be able to recognize emerging healthcare trends like the growing interest in herbal-synthetic hybrids in the PCOS treatment setting and introduce such preparations to the market at a much faster rate. Access to the newest therapeutic combinations can be a life-changer to the patient, should a doctor get such access.
- Openness and Accounting.
The contemporary companies of PCD are focused on transparency. They offer detailed illustrations, product glossary and certifications approved by DCGI to physicians. This evidence-based practice will allow medical practitioners to be assured that they are prescripting molecules that are safe besides being tested in the highest standards of bio-availability.
The Bottom Line
The change to PCD labels is not about abandoning multinational brands, it represents an adoption of a more customized, effective, and patient-focused healthcare delivery system.
Gynae PCD pharma franchise model is a rare chance to merge business development and quality clinical care to the entrepreneur and healthcare specialists desiring to leave a trace in the pharmaceutical industry. In the prospective of an Indian pharma, as long as the trust keeps shifting to such specific labels, it is more local and specialized.
*** Does that seek a partner in the excellence of women in healthcare? Discover the way Curivo Healthcare is reinventing the rules of the Gynae PCD pharma franchise arena by offering premium, DCGI-approved formulations with specific attention to the modern woman.